Ketamine as a Therapeutic Option, AI and Nurse Staffing, Naloxone Training, and Other March Issue Highlights
The March issue of AJN is now live.
Here are some highlights. Some articles are open access or temporarily free; others will require log-in for access.
In this month’s editorial, “A Turning Point in Psychiatry,” AJN‘s editor-in-chief Carl Kirton discusses key aspects of the current mental health crisis and explores whether a paradigm shift to more rapid treatment with drugs like ketamine and MDMA may be in sight for at least some percentage of those in need (the editorial is always free). Writes Kirton:
“The promise of ketamine therapy is not that it will ‘replace’ everything else, but that it may signal a broader turning point: psychiatry moving beyond slow-onset, monoamine-focused treatments toward interventions that target rapid symptom relief.”
In addition, the CE article (CE articles are free) in the March issue reviews current evidence on ketamine as a mental health treatment. Discussing the use of ketamine for treatment-resistant depression, the authors write:
This article provides “a foundation of clinical information that nurses should understand as they advise patients who are receiving or curious about ketamine” and discusses “the regulatory, ethical, and nursing implications of using ketamine in the treatment of mental health disorders.”


